Position in OGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$180,582
+$46,484 QoQ
Shares Held
13,337
+6.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#240
of 626 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SAGE RHINO CAPITAL LLC holds $11,215,095 across 12 Drug Manufacturers - General names. OGN ranks #12 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,014 | $2,415,652 | |
| 2 | JNJ |
Johnson & Johnson
|
6,868 | $1,744,265 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,448 | $1,342,568 | |
| 4 | NVS |
Novartis AG
|
7,947 | $1,245,453 | |
| 5 | AZN |
Astrazeneca PLC
|
5,336 | $1,011,812 | |
| 6 | AMGN |
Amgen Inc
|
2,387 | $864,380 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
5,127 | $647,745 | |
| 8 | ABBV |
AbbVie Inc.
|
2,265 | $569,964 |
All Filings in OGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $180,582 | 13,337 | Shares | Sole | 2026-08-03 | |
| 2025-09-30 | $134,098 | 12,556 | Shares | Sole | 2025-10-31 | |
| 2025-03-31 | $225,568 | 15,149 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $224,844 | 15,070 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $304,587 | 15,922 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $332,835 | 16,079 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $285,083 | 15,164 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $196,227 | 13,608 | Shares | Sole | 2024-02-05 | |
| No filing history on record for this holder in this stock. | ||||||